vs
Side-by-side financial comparison of SenesTech, Inc. (SNES) and CVR PARTNERS, LP (UAN). Click either name above to swap in a different company.
CVR PARTNERS, LP is the larger business by last-quarter revenue ($131.1M vs $421.0K, roughly 311.3× SenesTech, Inc.). CVR PARTNERS, LP runs the higher net margin — -7.8% vs -428.5%, a 420.7% gap on every dollar of revenue. On growth, CVR PARTNERS, LP posted the faster year-over-year revenue change (-6.1% vs -16.0%). SenesTech, Inc. produced more free cash flow last quarter ($-1.7M vs $-45.2M). Over the past eight quarters, CVR PARTNERS, LP's revenue compounded faster (1.3% CAGR vs 0.7%).
SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona.
CVR Partners, LP is a leading North American producer of nitrogen-based fertilizer products, primarily urea ammonium nitrate (UAN) and ammonia. It serves agricultural, industrial and commercial markets across the U.S. and Canada, delivering cost-effective, high-quality nutrient solutions for crop production and diverse industrial use cases.
SNES vs UAN — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $421.0K | $131.1M |
| Net Profit | $-1.8M | $-10.3M |
| Gross Margin | 55.3% | 4.4% |
| Operating Margin | -446.8% | -2.2% |
| Net Margin | -428.5% | -7.8% |
| Revenue YoY | -16.0% | -6.1% |
| Net Profit YoY | -43.7% | -156.1% |
| EPS (diluted) | $0.48 | $-0.98 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $421.0K | $131.1M | ||
| Q3 25 | $690.0K | $163.5M | ||
| Q2 25 | $625.0K | $168.6M | ||
| Q1 25 | $485.0K | $142.9M | ||
| Q4 24 | $501.0K | $139.6M | ||
| Q3 24 | $482.0K | $125.2M | ||
| Q2 24 | $459.0K | $132.9M | ||
| Q1 24 | $415.0K | $127.7M |
| Q4 25 | $-1.8M | $-10.3M | ||
| Q3 25 | $-1.3M | $43.1M | ||
| Q2 25 | $-1.6M | $38.8M | ||
| Q1 25 | $-1.7M | $27.1M | ||
| Q4 24 | $-1.3M | $18.3M | ||
| Q3 24 | $-1.5M | $3.8M | ||
| Q2 24 | $-1.6M | $26.2M | ||
| Q1 24 | $-1.8M | $12.6M |
| Q4 25 | 55.3% | 4.4% | ||
| Q3 25 | 62.8% | 37.0% | ||
| Q2 25 | 65.4% | 32.4% | ||
| Q1 25 | 64.5% | 29.7% | ||
| Q4 24 | 60.9% | 23.8% | ||
| Q3 24 | 65.4% | 14.7% | ||
| Q2 24 | 54.2% | 30.0% | ||
| Q1 24 | 32.5% | 21.4% |
| Q4 25 | -446.8% | -2.2% | ||
| Q3 25 | -195.2% | 31.0% | ||
| Q2 25 | -258.2% | 27.5% | ||
| Q1 25 | -342.9% | 24.2% | ||
| Q4 24 | -250.9% | 18.4% | ||
| Q3 24 | -321.0% | 8.8% | ||
| Q2 24 | -349.0% | 25.3% | ||
| Q1 24 | -444.1% | 15.7% |
| Q4 25 | -428.5% | -7.8% | ||
| Q3 25 | -188.1% | 26.3% | ||
| Q2 25 | -258.6% | 23.0% | ||
| Q1 25 | -343.3% | 19.0% | ||
| Q4 24 | -250.5% | 13.1% | ||
| Q3 24 | -313.9% | 3.0% | ||
| Q2 24 | -345.1% | 19.7% | ||
| Q1 24 | -441.4% | 9.9% |
| Q4 25 | $0.48 | $-0.98 | ||
| Q3 25 | $-0.28 | $4.08 | ||
| Q2 25 | $-0.87 | $3.67 | ||
| Q1 25 | $-1.28 | $2.56 | ||
| Q4 24 | $-0.15 | $1.73 | ||
| Q3 24 | $-2.07 | $0.36 | ||
| Q2 24 | $-3.08 | $2.48 | ||
| Q1 24 | $-3.56 | $1.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.6M | $69.2M |
| Total DebtLower is stronger | — | $569.1M |
| Stockholders' EquityBook value | $9.6M | — |
| Total Assets | $12.8M | $969.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.6M | $69.2M | ||
| Q3 25 | $10.2M | $156.2M | ||
| Q2 25 | $6.1M | $114.4M | ||
| Q1 25 | $1.7M | $121.8M | ||
| Q4 24 | $1.3M | $90.9M | ||
| Q3 24 | $2.5M | $110.5M | ||
| Q2 24 | $2.0M | $47.5M | ||
| Q1 24 | $3.6M | $64.6M |
| Q4 25 | — | $569.1M | ||
| Q3 25 | — | $569.1M | ||
| Q2 25 | — | $569.2M | ||
| Q1 25 | — | $569.3M | ||
| Q4 24 | — | $568.0M | ||
| Q3 24 | — | $547.7M | ||
| Q2 24 | — | $547.6M | ||
| Q1 24 | — | $547.4M |
| Q4 25 | $9.6M | — | ||
| Q3 25 | $11.3M | — | ||
| Q2 25 | $7.0M | — | ||
| Q1 25 | $2.9M | — | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $3.7M | — | ||
| Q2 24 | $3.1M | — | ||
| Q1 24 | $4.6M | — |
| Q4 25 | $12.8M | $969.5M | ||
| Q3 25 | $14.6M | $1.0B | ||
| Q2 25 | $10.4M | $998.0M | ||
| Q1 25 | $3.6M | $1.0B | ||
| Q4 24 | $3.3M | $1.0B | ||
| Q3 24 | $4.4M | $986.6M | ||
| Q2 24 | $4.0M | $959.4M | ||
| Q1 24 | $5.5M | $972.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.7M | $-21.6M |
| Free Cash FlowOCF − Capex | $-1.7M | $-45.2M |
| FCF MarginFCF / Revenue | -398.3% | -34.5% |
| Capex IntensityCapex / Revenue | 3.1% | 18.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.9M | $98.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.7M | $-21.6M | ||
| Q3 25 | $-1.4M | $91.7M | ||
| Q2 25 | $-1.1M | $24.1M | ||
| Q1 25 | $-1.6M | $55.4M | ||
| Q4 24 | $-1.2M | $12.8M | ||
| Q3 24 | $-1.4M | $86.7M | ||
| Q2 24 | $-1.6M | $8.6M | ||
| Q1 24 | $-1.8M | $42.4M |
| Q4 25 | $-1.7M | $-45.2M | ||
| Q3 25 | $-1.4M | $80.1M | ||
| Q2 25 | $-1.2M | $18.4M | ||
| Q1 25 | $-1.6M | $45.5M | ||
| Q4 24 | $-1.2M | $-5.6M | ||
| Q3 24 | $-1.4M | $82.3M | ||
| Q2 24 | $-1.6M | $2.4M | ||
| Q1 24 | $-1.8M | $34.3M |
| Q4 25 | -398.3% | -34.5% | ||
| Q3 25 | -205.9% | 49.0% | ||
| Q2 25 | -191.5% | 10.9% | ||
| Q1 25 | -328.5% | 31.9% | ||
| Q4 24 | -246.1% | -4.0% | ||
| Q3 24 | -296.1% | 65.7% | ||
| Q2 24 | -354.2% | 1.8% | ||
| Q1 24 | -441.2% | 26.9% |
| Q4 25 | 3.1% | 18.0% | ||
| Q3 25 | 6.1% | 7.1% | ||
| Q2 25 | 7.5% | 3.4% | ||
| Q1 25 | 7.4% | 6.9% | ||
| Q4 24 | 3.0% | 13.1% | ||
| Q3 24 | 5.8% | 3.6% | ||
| Q2 24 | 8.5% | 4.6% | ||
| Q1 24 | 0.5% | 6.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.13× | ||
| Q2 25 | — | 0.62× | ||
| Q1 25 | — | 2.04× | ||
| Q4 24 | — | 0.70× | ||
| Q3 24 | — | 22.78× | ||
| Q2 24 | — | 0.33× | ||
| Q1 24 | — | 3.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SNES
Segment breakdown not available.
UAN
| Product UAN | $64.7M | 49% |
| Product Ammonia | $50.5M | 39% |
| Products Other | $8.5M | 7% |
| Product Urea Products | $7.4M | 6% |
